Additionally, Representative Charles Boustany (R-La.) will speak on the "Healthcare Policy Panel." Boustany, a member of the House Republican Health Care Reform Working Group and a former cardiothoracic surgeon, delivered the GOP response to PresidentObama's speech on health care reform. He will speak alongsideRepresentative Anna Eshoo, (D-Calif.), and Tony Zook, CEO of AstraZeneca North America. Steve Usdin, Senior Editor, BioCentury Publications, Inc., will moderate the panel. Representative Bob Goodlatte (R-Va.) will make remarks at the "CEO & Investor Reception."

The Conference attracts hundreds ofsenior executives from the life sciences industry, as well as investors, capital sources, international delegations, entrepreneurs, researchers and professional service advisors. Mid-Atlantic Bio is co-hosted by the region's most influential life science and investor associations, MdBio Division of the Tech Council of Maryland (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO).

"Mid-Atlantic Bio is excited to offer Dean at this year's conference as an opportunity for attendees to gain insights on the coming impact of policy and regulatory changes," said Host committee member Richard Zakour, Ph.D., executive director of MdBio. "We look at this conference as a service to the industry because it offers an opportunity for the community to develop partnerships, share best practices, present research findings, and learn from provocative thought leaders."

PLENARY SESSION SPEAKERS:

R.J. Kirk CEO, Third Security and Intrexon

Tony Zook CEO, AstraZeneca North America President, MedImmune

Tom Watkins CEO, Human Genome Sciences

PANEL SESSIONS:

- Biofuels -- Innovative Biotechnology Meets Commercial Needs

- If Venture Capital Is Broken, Why Are So Many People Still Doing It?

- Innovative Life Science Business Strategies in an Uncertain Environment

- Without a Net -- CEOs Discuss How Their Companies Prosper, Even Today

- Accelerating and Enhancing Drug Development

- Biomarkers and Personalized Medicine: Challenges and Opportunities

- Go Where the Money Is: An Insider's Briefing on Accessing Federal Grants

- The Crown Jewels of Biotech Value: New Developments and Strategies for Intellectual Property

- How to Expedite Moving Submissions through the FDA in 2009

- Vaccines: Biotech's Next "Big Thing"

COMPANY PRESENTERS

Each year at Mid-Atlantic Bio, a number of life science companies are chosen to present before an audience of capital sources, including venture capitalists, angel investors, and various other qualified financing sources along with important industry professionals and potential strategic partners. This year we will have two distinct tracks”a "Showcase" track for later stage companies and a "Growth Watch" track for emerging companies.

INNOVATION CORRIDOR

The Mid-Atlantic Bio Innovation Corridor showcases the region's outstanding academic translational research and development through science posters on display at the conference. Corporate and academic entrepreneurs, researchers, faculty members, and students from Virginia, Maryland, the District of Columbia, and surrounding areas will present posters that highlight their latest research and findings.

ABOUT MID-ATLANTIC BIO

Mid-Atlantic Bio is co-hosted by the region's most influential life science and investor associations, MdBio Division of the Tech Council of Maryland (TCM/MdBio), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO). Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations. For more information, or to register or sponsor, please visit www.midatlanticbio.org.

A service of YellowBrix, Inc.